Effect of Empagliflozin on Electrolytes and Lipid Profiles in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Introduction

Studies examining the effect of Empagliflozin in patients with type 2 diabetes have reported different results regarding the effect of this drug on electrolytes and lipid profiles. This study aimed to evaluate the effect of Empagliflozin on electrolytes and lipid profiles in patients with type 2 diabetes.

Materials and Methods

In this systematic meta-analysis, clinical trials published in the Web of Science, Scopus, PubMed, and Cochrane Library databases up to April 2022 were reviewed. Information on the mean and standard deviations of electrolytes, including phosphate, calcium, sodium, potassium, magnesium, and lipid parameters, including total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides, before receiving Empagliflozin was extracted from the selected studies and analyzed.

Results

A total of seven clinical trials with 398 patients were analyzed. The sodium, potassium, phosphate, and magnesium levels remained unchanged or slightly changed after receiving different doses of Empagliflozin. Estimation of the standardized mean difference of calcium after receiving 10 mg of Empagliflozin was insignificant. The standardized mean difference in levels of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides was insignificant after receiving different doses of Empa gliflozin.

Conclusion

Administration of Empagliflozin in patients with type 2 diabetes does not affect phosphate, calcium, sodium, potassium, magnesium, total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. However, further research is needed due to the small number of studies and conflicting results on the issue.

Language:
Persian
Published:
Iranian Journal of Endocrinology and Metabolism, Volume:23 Issue: 5, 2022
Pages:
341 to 350
magiran.com/p2470345  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!